Net worth tracking
Login Sign Up
  • All Opinions
  • Top Picks
  • Discover
  • Companies
  • Experts
WATCH LIST
Home » Daily

Disappointing Gilead drug report snuffs Thursday rally

Allan TongAllan Tong Posted On April 23, 2020
0
375 Views
0
0
Shares
  • Share On Facebook
  • Tweet It

Toronto and New York indices were rallying until midday Thursday when “inconclusive” results were released about Gilead’s COVID-19 treatment. Many investors were betting on the drug, remdesivir, after trial results were mistakenly published on the World Health Organization’s website earlier this month. Gilead tumbled 4.34%. The main New York indices closed flat, and the TSX shed 0.26%.

In Toronto, only energy and materials finished in the green, as oil continued to rebound from historic lows early this week. Paramount Resources was the biggest gainer, soaring 30% and led a big pack of oil names that included Cenovus Energy, rallying almost 7% in heavy trading. WTI and WCS continued to climb, both rising $3 to $17 and $8 (respectively) per barrel.

Likewise on Wall Street, Schlumberger climbed 7.69%. Meanwhile, investors continue to hunger for food stocks as Beyond Meat jumped 12.8%. Otherwise, on the Dow healthcare, energy and industrials gained. For once, tech stocks had a quiet, flat session. After hours, Intel dropped 5% on a negative earnings report. Given this relatively quiet session, the VIX slipped modestly by -1.43%, which is welcome news to investors rocked by wild swings in the past two months.

🧫 Gilead Sciences Inc. -4.34%
🛢 Paramount Resources +30%
🛢 Cenovus Energy +7%
🛢 Schlumberger Ltd. +7.69%
🥩 Beyond Meat Inc. +12.8%
💽 Intel -5%

Post Views: 375
0
Shares
  • Share On Facebook
  • Tweet It




Trending Now
Fortis Inc., Power Corp and More at 52-week Highs (Apr 07-13)
Melisa R. H. April 14, 2021
Stride, Inc., Chubb Limited and 20 Stock and 1 ETF Top Picks (Apr 09-15)
Melisa R. H. April 16, 2021
Read Next

Markets rise to end a flat week as Trudeau announces rent relief

  • We're the Stock Chasers
    Hi! We are the Stock Chasers. We write about investing and finance tools we love. We’re passionate about fintech and we invest almost all our affiliate and advertising revenues into the development of Stockchase and Wealthica. We hope you enjoy the stock ideas and product reviews!
  • Join 39,652 Investors

    Winning in the Market eBook
    We deliver stock ideas to your inbox. Sign up free, get the ebook!

  • Top Reviews

    • The Ugly Truth About Identity Theft – Free Credit Report
      10
    • Questrade Review: Pros & Cons of Trading with Questrade Canada (2021)
      8.5
    • Questrade vs Others | The Review Competitors Don’t Want you to Read (2021)
      7.4
  • Popular Posts

    • Fortis Inc., Power Corp and More at 52-week Highs (Apr 07-13)
    • Stride, Inc., Chubb Limited and 20 Stock and 1 ETF Top Picks (Apr 09-15)
    • Aphria Inc, Cogeco Cable and More Earnings Reports this Week (Apr 12-16)
    • 3 Underestimated Automation Stocks
    • Wine and Pizza: 3 Uplifting Food Stocks
  • Stock Lists

    • 3 Promising Stock Upgrades: SNAP, Uber, Corus
      April 13, 2021
    • April Showers and Flowers: 4 Covid Vaccination Stocks...
      April 6, 2021
    • Wine and Pizza: 3 Uplifting Food Stocks
      March 30, 2021
    • 3 Underestimated Automation Stocks
      March 23, 2021
    • 5G Stocks Are Coming -- Are You Ready?
      March 16, 2021


  • Get $50 in free trades.


  • Stockchase neither recommends nor promotes any investment strategies.

    About us : Privacy & Terms : Contact us

© Stockchase Inc.
Press enter/return to begin your search